M&A Deal Summary |
|
|---|---|
| Date | 2008-11-21 |
| Target | Alpharma |
| Sector | Life Science |
| Buyer(s) | King Pharmaceuticals |
| Deal Type | Add-on Acquisition |
| Deal Value | 1.6B USD |
| Advisor(s) | BofA Securities (Financial) Simpson Thacher & Bartlett (Legal) |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Company |
|---|---|
| Founded | 1993 |
| Sector | Life Science |
| Employees | 2,600 |
| Revenue | 1.7B USD (2009) |
King Pharmaceuticals LLC is a vertically integrated branded pharmaceutical company. King seeks to capitalize on opportunities in the pharmaceutical industry through the development, including through in-licensing arrangements and acquisitions, of novel branded prescription pharmaceutical products and technologies that complement the Company's focus in specialty-driven markets, particularly neuroscience and hospital. King's wholly owned subsidiary, Alpharma, LLC, is also a leader in the development, registration, manufacture and marketing of pharmaceutical products for food producing animals.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 2 |
| Sector (Life Science) | 1 of 2 |
| Type (Add-on Acquisition) | 1 of 2 |
| State (New Jersey) | 1 of 2 |
| Country (United States) | 1 of 2 |
| Year (2008) | 1 of 2 |
| Size (of disclosed) | 2 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2008-12-29 |
Alpharma Pharmaceuticals
Piscataway, New Jersey, United States Alpharma Pharmaceuticals Inc. engages in the manufacturing of pharmaceutical products. |
Buy | $16.0B |
